Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT00350051
First received: July 7, 2006
Last updated: October 31, 2014
Last verified: October 2014